- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02350374
Carbohydrate Counting in Children and Adolescents With Type 1 Diabetes
Analysis of the Individual Variation of the Carbohydrate Amount at Each Meal in Children and Adolescents With Type 1 Diabetes Using the Carbohydrate Counting Method
Study Overview
Detailed Description
The chalenge of the treatment of children and adolescents with type 1 diabetes is to maintain a normoglycemia to prevent the complications of diabetes. The post prandial glycemic control is directly inflenced by the CHO content of the meal and the carbohydrates must represent about 55% of the daily needs. There is a linear relation between carbohydrate intake and insuline need. CHO counting is a technique to match a bolus insuline dose to the total carbohydrate content of the meal. An insulin to carbohydrate ratio is used. The method contrasts with fixed insulin regimen. There is a lack of studies on CHO counting particulary in pediatric population. However, there are currently international recommendations supporting the use of CHO counting in the management of type 1 diabetes because it improves the quality of life, tends to improve the HbA1c and limits hypoglycemia without increasing the BMI. There is no pediatric study on the variation of the amount of CHO at each of the main 4 daily meals.
Aims The investigators hypothesize that children vary greatly their total meal CHO .This is an argument for this technique.
Primary aim :
To assess how children and adolescents (aged 1 to 18) use this possibility to change the amount of CHO at breakfast, at lunch, at snack, at dinner and from day to day.
Secondary aims :
- To identify a correlation between the variation of CHO and environnemental factors such as school or disease and medical factors such as glycemic control and BMI.
- To compare the total CHO intake of our pediatric population with international recommendations Methods A logbook is given to the patient to detail the amount of carbohydrates in the meal and place and event during these meal.
This self monitoring logbook must be completed over 28 days between two consultations.
The investigators will include 80 patients during 18 months
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nice, France, 06200
- Fondation Lenval
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Treated for type 1 diabetes with a basal bolus regimen and practicing counting carbohydrates for nine months or more
- With autoantibodies positive (anti-gad, anti-ia2, anti-islets ) or HLA typing predisposing to type 1 diabetes
- Aged 1 to 18 years
- affiliation to a social security scheme
- Less than three oversights of bolus insulin in the week prior to inclusion
Exclusion Criteria:
- Aged less than 1 or more than 18 years
- Autoantibody negative and HLA does not predispose to type 1 diabetes
- No affiliation to a social security scheme
- More than two omissions of bolus insulin in the week before the inclusion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: carbohydrate counting
patients must fill their logbook during 28 days
|
patients must fill their logbook with the following data:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The individual variation of CHO amount at each main meal : Breakfast, Lunch, Snacks, Dinner
Time Frame: each day during 28 days
|
the patients must fill their logbook during 28 days
|
each day during 28 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marie HOFLACK, PhD, Fondation Lenval
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-HPNCL-05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
GentiBio, IncRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes (T1D)United States
-
Stanford UniversityUniversity College Dublin; The Leona M. and Harry B. Helmsley Charitable TrustNot yet recruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM) | Exercise Physiology | Type 1 Diabetes MellitisUnited States
-
Dasman Diabetes InstituteRecruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM)Kuwait
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
Insulet CorporationNot yet recruitingType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes (DM)New Zealand
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
Clinical Trials on carbohydrate counting
-
Soroka University Medical CenterCompletedDiabetes Mellitus | Insulin Sensitivity | Carbohydrates | HbA1C
-
Sohag UniversityNot yet recruiting
-
Universidade Nova de LisboaWithdrawnType 1 DiabetesPortugal
-
Lia BallyCompleted
-
The Hospital for Sick ChildrenThe Lawson FoundationCompletedAn Evaluation of Internet-based Carbohydrate Counting Education for Adolescents With Type 1 DiabetesType 1 Diabetes MellitusCanada
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenCompletedGlucose Metabolism Disorders | Type1diabetes | Type1 Diabetes MellitusDenmark
-
Medipol UniversityCompleted
-
Hasan Kalyoncu UniversityCompleted
-
IRCCS San RaffaeleCompletedDiabetes Mellitus, Type 1 | Insulin Pump, ProgrammableItaly
-
University of Colorado, DenverRecruitingType 1 DiabetesUnited States